Talphera (TLPH) Consolidated Net Income (2010 - 2025)
Talphera's (TLPH) quarterly Consolidated Net Income came in at $73000.0 in Q1 2025, up 708.33% quarter-over-quarter from -$12000.0 in Q4 2023.
Talphera (TLPH) Consolidated Net Income (2010 - 2025) Analysis & Trends
Talphera's Consolidated Net Income history runs 15 years deep, the most recent figure standing at $73000.0 for Q1 2025.
- On a quarterly basis, Consolidated Net Income changed N/A year-over-year to $73000.0 in Q1 2025; TTM through Dec 2025 was $73000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $73000.0, changed N/A from the prior year.
- Consolidated Net Income rose to $73000.0 in Q1 2025 per TLPH's latest filing, from -$12000.0 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $8.2 million in Q1 2023 and bottomed at -$9.9 million in Q2 2021.
- The 4-year median for Consolidated Net Income is -$1.5 million (2022), against an average of -$2.4 million.
- Across the five-year window, Consolidated Net Income plunged 185.61% in 2022 and surged 302.41% in 2023, its largest moves.
- Year by year, Consolidated Net Income stood at -$542000.0 in 2021, then plunged by 185.61% to -$1.5 million in 2022, then jumped by 99.22% to -$12000.0 in 2023, then jumped by 708.33% to $73000.0 in 2025.
- Per Business Quant, the three latest TLPH Consolidated Net Income figures stand at $73000.0 (Q1 2025), -$12000.0 (Q4 2023), and $61000.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 8.22 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | -2.11 Mn |
| Jun 30, 2022 | -3.65 Mn |
| Mar 31, 2022 | -4.06 Mn |
| Dec 31, 2021 | -542,000.00 |
| Sep 30, 2021 | -8.38 Mn |
| Jun 30, 2021 | -9.85 Mn |
| Mar 31, 2021 | -9.74 Mn |
| Dec 31, 2020 | -8.92 Mn |
| Sep 30, 2020 | -8.93 Mn |
| Jun 30, 2020 | -6.61 Mn |
| Mar 31, 2020 | -16.77 Mn |
| Dec 31, 2019 | -14.42 Mn |
| Sep 30, 2019 | -12.73 Mn |
| Jun 30, 2019 | -12.41 Mn |